FR2160410A1 - - Google Patents

Info

Publication number
FR2160410A1
FR2160410A1 FR7239688A FR7239688A FR2160410A1 FR 2160410 A1 FR2160410 A1 FR 2160410A1 FR 7239688 A FR7239688 A FR 7239688A FR 7239688 A FR7239688 A FR 7239688A FR 2160410 A1 FR2160410 A1 FR 2160410A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7239688A
Other versions
FR2160410B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of FR2160410A1 publication Critical patent/FR2160410A1/fr
Application granted granted Critical
Publication of FR2160410B1 publication Critical patent/FR2160410B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C08L83/04—Polysiloxanes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/20—Polysiloxanes containing silicon bound to unsaturated aliphatic groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7239688A 1971-11-20 1972-11-09 Expired FR2160410B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2158226A DE2158226B2 (de) 1971-11-20 1971-11-20 Verwendung von Dimethylpolysiloxan-Elastomeren als Arzneimittelwirkstoffträger

Publications (2)

Publication Number Publication Date
FR2160410A1 true FR2160410A1 (fr) 1973-06-29
FR2160410B1 FR2160410B1 (fr) 1975-08-08

Family

ID=5825997

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7239688A Expired FR2160410B1 (fr) 1971-11-20 1972-11-09

Country Status (23)

Country Link
US (1) US4230686A (fr)
JP (1) JPS5647885B2 (fr)
AR (1) AR192502A1 (fr)
AT (1) AT326270B (fr)
BE (1) BE791632A (fr)
CA (1) CA993359A (fr)
CH (1) CH604727A5 (fr)
CS (1) CS195670B2 (fr)
DD (1) DD103387A5 (fr)
DE (1) DE2158226B2 (fr)
DK (1) DK136399C (fr)
EG (1) EG10868A (fr)
ES (1) ES408716A1 (fr)
FI (1) FI53919C (fr)
FR (1) FR2160410B1 (fr)
GB (1) GB1412969A (fr)
HU (1) HU166024B (fr)
IE (1) IE37160B1 (fr)
IL (1) IL40868A (fr)
NL (1) NL7215705A (fr)
NO (1) NO138189C (fr)
SE (1) SE384970B (fr)
ZA (1) ZA728198B (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2331375A1 (fr) * 1975-11-17 1977-06-10 Haessle Ab Procede pour l'obtention de preparations avec liberation reglee d'un principe actif
FR2364660A1 (fr) * 1976-09-17 1978-04-14 Richter Gedeon Vegyeszet Enrobage assurant une liberation reguliere d'ingredients actifs de compositions biologiquement actives et procede pour leur preparation
EP0056697A2 (fr) * 1981-01-09 1982-07-28 Robert W. Rand Compositions injectables utilisable pour le chauffage par induction de néoplasmes
EP0127282A2 (fr) * 1983-05-26 1984-12-05 Alza Corporation Distributeur pour substances actives
FR2603191A1 (fr) * 1986-08-27 1988-03-04 Harvey Alex Ind Ltd Procede de fabrication d'un dispositif pour liberer un produit chimique de fecondation dans un milieu ambiant recepteur et dispositif obtenu par ce procede.
EP0281236A2 (fr) * 1987-02-28 1988-09-07 Dow Corning Limited Dispositif de libération d'un médicament et procédé pour sa fabrication
FR2653337A1 (fr) * 1989-10-23 1991-04-26 Dow Corning Sa Element a liberation prolongee et procede pour le fabriquer.

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792502A (fr) * 1971-12-09 1973-06-08 Upjohn Co Nouvelles formes pharmaceutiques et leur procede de preparation
US4155991A (en) * 1974-10-18 1979-05-22 Schering Aktiengesellschaft Vaginal ring
US4326523A (en) * 1980-08-25 1982-04-27 International Minerals & Chemical Corp. Method of supplying micronutrients to animals
JPS6128789U (ja) * 1984-07-23 1986-02-20 三井造船株式会社 クレ−ン
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
JPS62113191U (fr) * 1986-04-28 1987-07-18
FR2611733B1 (fr) * 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition a base de gomme diorganopolysiloxane contenant de l'iode pour le traitement des eaux
FR2611735B1 (fr) * 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition elastomere silicone polyaddition contenant de l'iode pour le traitement de l'eau
US5028430A (en) * 1987-05-08 1991-07-02 Syntex (U.S.A.) Inc. Delivery systems for the controlled administration of LHRH analogs
FR2618329B1 (fr) * 1987-07-22 1997-03-28 Dow Corning Sa Procede de fabrication d'un anneau capable d'assurer la liberation d'un agent therapeutique, et anneau fabrique par ce procede
US4894231A (en) * 1987-07-28 1990-01-16 Biomeasure, Inc. Therapeutic agent delivery system
US5019378A (en) * 1987-12-29 1991-05-28 Cuno, Incorporated Elastomeric composition containing therapeutic agents and articles manufactured therefrom
US5019601A (en) * 1987-12-29 1991-05-28 Cuno, Incorporated Elastomeric composition containing therapeutic agents and articles manufactured therefrom
US4867968A (en) * 1987-12-29 1989-09-19 Florida-Kansas Health Care, Inc. Elastomeric composition containing therapeutic agents and articles manufactured therefrom
AU3432689A (en) * 1988-03-24 1989-10-16 Bukh Meditec A/S Controlled release composition
NO178843C (no) * 1988-07-11 1996-06-19 Sspl Sa Safe Sex Prod Licens Fremgangsmåte for fremstilling av et farmasöytisk preparat for å forhindre seksuelt overförbare sykdommer
FR2643572A1 (fr) * 1988-12-22 1990-08-31 Rhone Poulenc Chimie Procede d'encapsulation de particules par pelliculage au moyen d'un copolymere silicone thermoplastique
FR2653338B1 (fr) * 1989-10-23 1994-06-10 Dow Corning Sa Formulation pour des pansements a liberation prolongee de medicament et son utilisation.
GB2252497B (en) * 1991-02-04 1995-01-18 Elsimar Metzker Coutinho Pharmaceutical composition
US6142984A (en) * 1997-12-30 2000-11-07 Playtex Products, Inc. Removal string for tampon pledget
US6207717B1 (en) * 1999-01-12 2001-03-27 Dow Corning Corporation Entrapment of vitamins with an elastomeric silicone polyether
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
US6951654B2 (en) * 2001-03-27 2005-10-04 Galen (Chemicals) Limited Intravaginal drug delivery devices for the administration of an antimicrobial agent
US7060057B2 (en) * 2003-02-24 2006-06-13 Nini Policappelli Comfortable tampon
US8870814B2 (en) * 2003-07-31 2014-10-28 Boston Scientific Scimed, Inc. Implantable or insertable medical devices containing silicone copolymer for controlled delivery of therapeutic agent
DE102004054040A1 (de) * 2004-11-05 2006-05-11 Bayer Innovation Gmbh Wirkstoffhaltige Silikonelastomere
US20090148520A1 (en) * 2005-07-08 2009-06-11 Hiroaki Arima Tablet
DE102006020644A1 (de) * 2006-04-28 2007-10-31 Bayer Innovation Gmbh Antiseptikahaltige Silikonelastomere
WO2008027404A2 (fr) * 2006-08-29 2008-03-06 Playtex Products, Inc. Dispositif d'extraction de tampon hygiénique
WO2008097851A1 (fr) * 2007-02-02 2008-08-14 Warner Chilcott Company, Inc. Compositions de tétracycline pour une administration topique
CA2725578A1 (fr) * 2008-04-24 2009-10-29 Evestra, Inc. Formes galeniques contraceptives orales renfermant un progestogene disperse dans un polymere gastroresistant et renfermant en outre un oestrogene
US20100040671A1 (en) * 2008-08-12 2010-02-18 Ahmed Salah U Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof
US8420153B2 (en) * 2008-09-19 2013-04-16 Mentor Worldwide Llc Coating with antimicrobial agents
US8419793B2 (en) * 2008-09-19 2013-04-16 Mentor Worldwide Llc Coating with antimicrobial agents
EP2444464A1 (fr) * 2010-10-21 2012-04-25 Centre National de la Recherche Scientifique (CNRS) Nouveau (bio)matériau neutre
EP2680814A2 (fr) * 2011-03-03 2014-01-08 Allergan, Inc. Formulations ophtalmiques non aqueuses à base de silicone
EP2982352B1 (fr) * 2014-06-28 2018-10-03 Laboratorios Andrómaco S.A. Pessaire cervicale contenant de la progestérone à libération prolongée, soutenue et continue, utile pour la prévention de l'accouchement prématuré
GB201616223D0 (en) * 2016-09-23 2016-11-09 University College Cardiff Consultants Limited Topical treatment patch
ES2930330T3 (es) * 2018-04-19 2022-12-12 Yipurun Shanghai Biotechnology Co Ltd Membrana elástica que tiene una función de reactivación de la capa basal endometrial en una cavidad uterina y método de preparación de la membrana elástica

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3279996A (en) * 1962-08-28 1966-10-18 Jr David M Long Polysiloxane carrier for controlled release of drugs and other agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127363A (en) * 1955-08-05 1964-03-31 Process for the manufacture of elasto-
BE553159A (fr) * 1955-12-05
US3020260A (en) * 1960-08-18 1962-02-06 Dow Corning Organosiloxane potting compound
US3220972A (en) * 1962-07-02 1965-11-30 Gen Electric Organosilicon process using a chloroplatinic acid reaction product as the catalyst
JPS4810947B1 (fr) * 1969-08-15 1973-04-09

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3279996A (en) * 1962-08-28 1966-10-18 Jr David M Long Polysiloxane carrier for controlled release of drugs and other agents

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2331375A1 (fr) * 1975-11-17 1977-06-10 Haessle Ab Procede pour l'obtention de preparations avec liberation reglee d'un principe actif
FR2364660A1 (fr) * 1976-09-17 1978-04-14 Richter Gedeon Vegyeszet Enrobage assurant une liberation reguliere d'ingredients actifs de compositions biologiquement actives et procede pour leur preparation
EP0056697A2 (fr) * 1981-01-09 1982-07-28 Robert W. Rand Compositions injectables utilisable pour le chauffage par induction de néoplasmes
EP0056697A3 (en) * 1981-01-09 1984-09-19 Robert W. Rand Injectable compositions and apparatus suitable for use in inductively heating neoplasms
EP0127282A2 (fr) * 1983-05-26 1984-12-05 Alza Corporation Distributeur pour substances actives
EP0127282A3 (fr) * 1983-05-26 1986-07-16 Alza Corporation Distributeur pour substances actives
FR2603191A1 (fr) * 1986-08-27 1988-03-04 Harvey Alex Ind Ltd Procede de fabrication d'un dispositif pour liberer un produit chimique de fecondation dans un milieu ambiant recepteur et dispositif obtenu par ce procede.
EP0281236A2 (fr) * 1987-02-28 1988-09-07 Dow Corning Limited Dispositif de libération d'un médicament et procédé pour sa fabrication
EP0281236A3 (en) * 1987-02-28 1989-06-07 Dow Corning Limited Pharmaceutical delivery device
FR2653337A1 (fr) * 1989-10-23 1991-04-26 Dow Corning Sa Element a liberation prolongee et procede pour le fabriquer.
EP0425154A1 (fr) * 1989-10-23 1991-05-02 Dow Corning France S.A. Eléments à libération prolongée

Also Published As

Publication number Publication date
FI53919C (fi) 1978-12-15
DE2158226A1 (de) 1973-05-24
CS195670B2 (en) 1980-02-29
AU4890172A (en) 1974-05-16
IE37160L (en) 1973-05-20
IL40868A0 (en) 1973-01-30
CA993359A (en) 1976-07-20
HU166024B (fr) 1974-12-28
ATA981472A (de) 1975-02-15
FR2160410B1 (fr) 1975-08-08
AT326270B (de) 1975-12-10
DD103387A5 (fr) 1974-01-20
US4230686A (en) 1980-10-28
FI53919B (fi) 1978-05-31
NO138189B (no) 1978-04-17
DE2158226B2 (de) 1981-02-19
DK136399C (da) 1978-03-13
JPS4858118A (fr) 1973-08-15
NL7215705A (fr) 1973-05-22
IE37160B1 (en) 1977-05-25
IL40868A (en) 1975-10-15
DK136399B (da) 1977-10-10
EG10868A (en) 1980-03-31
AR192502A1 (es) 1973-02-21
JPS5647885B2 (fr) 1981-11-12
ES408716A1 (es) 1975-11-01
SE384970B (sv) 1976-05-31
ZA728198B (en) 1973-07-25
NO138189C (no) 1978-07-26
BE791632A (fr) 1973-05-21
GB1412969A (en) 1975-11-05
CH604727A5 (fr) 1978-09-15

Similar Documents

Publication Publication Date Title
FR2160410B1 (fr)
ATA136472A (fr)
AR196074A1 (fr)
AU2658571A (fr)
AU2684071A (fr)
AU2564071A (fr)
AU2742671A (fr)
AU2485671A (fr)
AU2726271A (fr)
AU2503871A (fr)
AU2724971A (fr)
AU2577671A (fr)
AU2880771A (fr)
AU2669471A (fr)
AU2486471A (fr)
AU2473671A (fr)
AU2456871A (fr)
AU2706571A (fr)
AU2455871A (fr)
AU2415871A (fr)
AU2875571A (fr)
AU2755871A (fr)
AU2399971A (fr)
AU1109576A (fr)
AU2588771A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse